跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FINGOLIMOD PHARMATHEN 0,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FINGOLIMOD PHARMATHEN 0,5 MG CAPSULAS DURAS EFG
Approved
STANDARD
FINGOLIMOD PHARMATHEN 0,5 MG CAPSULAS DURAS EFG
Pharmathen S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 20, 2020
Approval ID
eaf462cb7b26f203
Company
Pharmathen S.A.
Type
Standard
Approval Details
Approval Id
eaf462cb7b26f203
Drug Cima Aemps Name
FINGOLIMOD PHARMATHEN 0,5 MG CAPSULAS DURAS EFG
Register Number
85499
Holder Company Name
Pharmathen S.A.
Marketing Company Name
Pharmathen S.A.
Holder Company Detail Path
/organization/pharmathen-s-a
Marketing Company Detail Path
/organization/pharmathen-s-a
Authorization Date
2020-10-20
Dosage Form
CÁPSULA DURA
Dose
0.5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Pharmathen S.A.
Company Detail Path
/organization/pharmathen-s-a
Company Information
Pharmaceutical Company Name
PHARMATHEN S.A.
Country Name
Greece
City Name
pallini,sterea ellada and evoia,country_gr
Address
6 Dervenakion
Active Ingredients
FINGOLIMOD HIDROCLORURO
0,56 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 20, 2020
Approval ID
eaf462cb7b26f203
Type
Standard
Back to CIMA-AEMPS Approvals
